Xiaolin Wang
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Xiaolin Wang
The proxy statement of Revolution Medicines, Inc. reports total compensation of $3,054,190 for Xiaolin Wang in fiscal 2024, including a base salary of $455,500. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Revolution Medicines, Inc. (RVMD)
Proxy statement
Start not stated–2025-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Revolution Medicines, Inc. (RVMD) | — | $455,500 | $3,054,190 |
| 2023 | Revolution Medicines, Inc. (RVMD) | — | $415,737 | $3,230,922 |
| 2022 | Revolution Medicines, Inc. (RVMD) | — | $400,000 | $1,791,780 |
| 2021 | Revolution Medicines, Inc. (RVMD) | — | $377,833 | $2,167,809 |
Recent activity
No call appearances or filed executive changes recorded yet.